Expression of heat shock proteins in medulloblastoma: Laboratory investigation

Journal of Neurosurgery: Pediatrics

Volumn 12, Issue 5, 2013, Pages 452-457

  Alexiou, George A ^e   Vartholomatos, George ^b   Stefanaki, Kalliopi ^a   Patereli, Amalia ^a   Dova, Lefkothea ^b   Karamoutsios, Achilleas ^b   Lallas, George ^c   Sfakianos, George ^a   Moschovi, Maria ^d   Prodromou, Neofytos ^a  

^a AGHIA SOPHIA CHILDREN S HOSPITAL   (Greece)

^b UNIVERSITY HOSPITAL OF IOANNINA   (Greece)

^c Flowcytogen Laboratories Ltd Koropi   (Greece)

^d UNIVERSITY OF ATHENS   (Greece)

^e not available   (Greece)

Author keywords

Bcl 2; Children; Heat Shock Protein; Immunohistochemistry; Ki 67; Medulloblastoma; Multiplex Bead Array Assay; Oncology; P53

Indexed keywords

CARBOPLATIN; CHAPERONIN 60; CISPLATIN; CYCLOPHOSPHAMIDE; ETOPOSIDE; HEAT SHOCK PROTEIN; HEAT SHOCK PROTEIN 27; HEAT SHOCK PROTEIN 40; HEAT SHOCK PROTEIN 70; HEAT SHOCK PROTEIN 90; HEAT SHOCK PROTEIN 90 ALPHA; METHOTREXATE; PROTEIN BCL 2; PROTEIN KINASE B; PROTEIN P53; UNCLASSIFIED DRUG; VINCRISTINE;

ADOLESCENT; ARTICLE; BRAIN SURGERY; CANCER PROGNOSIS; CHILD; CLINICAL ARTICLE; COMBINATION CHEMOTHERAPY; CRANIOSPINAL IRRADIATION; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; MEDULLOBLASTOMA; PRESCHOOL CHILD; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; RETROSPECTIVE STUDY; SCHOOL CHILD;

EID: 84887037839     PISSN: 19330707     EISSN: 19330715     Source Type: Journal    
DOI: 10.3171/2013.7.PEDS1376     Document Type: Article

References (35)

1. Alexiou GA, Moschovi M, Stefanaki K, Sfakianos G, Prodromou N: Epidemiology of pediatric brain tumors in Greece (1991-2008). Experience from the Agia Sofia Children's Hospital. Cent Eur Neurosurg 72:1-4, 2011.
2. Ayrault O, Godeny MD, Dillon C, Zindy F, Fitzgerald P, Roussel MF, et al: Inhibition of Hsp90 via 17-DMAG induces apoptosis in a p53-dependent manner to prevent medulloblastoma. Proc Natl Acad Sci U S A 106:17037-17042, 2009.
3. Balaburski GM, Leu JI, Beeharry N, Hayik S, Andrake MD, Zhang G, et al: A modified HSP70 inhibitor shows broad activity as an anticancer agent. Mol Cancer Res 11:219-229, 2013.
4. Ciocca DR, Calderwood SK: Heat shock proteins in cancer: Diagnostic, prognostic, predictive, and treatment implications. Cell Stress Chaperones 10:86-103, 2005. (Pubitemid 40942470)
5. Ciocca DR, Rozados VR, Cuello-Carrión FD, Gervasoni SI, Matar P, Scharovsky OG: Hsp25 and Hsp70 in rodent tumors treated with doxorubicin and lovastatin. Cell Stress Chaperones 8:26-36, 2003. (Pubitemid 36444088)
6. Cruickshanks N, Shervington L, Patel R, Munje C, Thakkar D, Shervington A: Can hsp90alpha-targeted siRNA combined with TMZ be a future therapy for glioma? Cancer Invest 28: 608-614, 2010.
7. Ellison DW, Dalton J, Kocak M, Nicholson SL, Fraga C, Neale G, et al: Medulloblastoma: clinicopathological correlates of SHH, WNT, and non-SHH/WNT molecular subgroups. Acta Neuropathol 121:381-396, 2011.
8. Elshal MF, McCoy JP: Multiplex bead array assays: performance evaluation and comparison of sensitivity to ELISA. Methods 38:317-323, 2006.
9. Garrido C: Size matters: of the small HSP27 and its large oligomers. Cell Death Differ 9:483-485, 2002. (Pubitemid 34521175)
10. Giangaspero F, Wellek S, Masuoka J, Gessi M, Kleihues P, Ohgaki H: Stratification of medulloblastoma on the basis of histopathological grading. Acta Neuropathol 112:5-12, 2006. (Pubitemid 43942157)
11. Graner MW, Bigner DD: Chaperone proteins and brain tumors: potential targets and possible therapeutics. Neuro Oncol 7:260-278, 2005.
12. Hartmann W, Digon-Söntgerath B, Koch A, Waha A, Endl E, Dani I, et al: Phosphatidylinositol 3-kinase/AKT signaling is activated in medulloblastoma cell proliferation and is associated with reduced expression of PTEN. Clin Cancer Res 12:3019-3027, 2006. (Pubitemid 43837346)
13. Hauser P, Hanzély Z, Jakab Z, Oláh L, Szabó E, Jeney A, et al: Expression and prognostic examination of heat shock proteins (HSP 27, HSP 70, and HSP 90) in medulloblastoma. J Pediatr Hematol Oncol 28:461-466, 2006. (Pubitemid 44114556)
14. Jhaveri K, Miller K, Rosen L, Schneider B, Chap L, Hannah A, et al: A phase I dose-escalation trial of trastuzumab and alvespimycin hydrochloride (KOS-1022; 17 DMAG) in the treatment of advanced solid tumors. Clin Cancer Res 18: 5090-5098, 2012.
15. Kato S, Kato M, Hirano A, Takikawa M, Ohama E: The immunohistochemical expression of stress-response protein (srp) 60 in human brain tumours: relationship of srp 60 to the other five srps, proliferating cell nuclear antigen and p53 protein. Histol Histopathol 16:809-820, 2001. (Pubitemid 32700391)
16. Khalil AA, Kabapy NF, Deraz SF, Smith C: Heat shock proteins in oncology: Diagnostic biomarkers or therapeutic targets? Biochim Biophys Acta 1816:89-104, 2011.
17. Khong T, Spencer A: Targeting HSP 90 induces apoptosis and inhibits critical survival and proliferation pathways in multiple myeloma. Mol Cancer Ther 10:1909-1917, 2011.
18. Leng AM, Liu T, Yang J, Cui JF, Li XH, Zhu YN, et al: The apoptotic effect and associated signalling of HSP90 inhibitor 17-DMAG in hepatocellular carcinoma cells. Cell Biol Int 36:893-899, 2012.
19. Massimino M, Antonelli M, Gandola L, Miceli R, Pollo B, Biassoni V, et al: Histological variants of medulloblastoma are the most powerful clinical prognostic indicators. Pediatr Blood Cancer 60:210-216, 2013.
20. McManamy CS, Lamont JM, Taylor RE, Cole M, Pearson AD, Clifford SC, et al: Morphophenotypic variation predicts clinical behavior in childhood non-desmoplastic medulloblastomas. J Neuropathol Exp Neurol 62:627-632, 2003. (Pubitemid 36682635)
21. McManamy CS, Pears J, Weston CL, Hanzely Z, Ironside JW, Taylor RE, et al: Nodule formation and desmoplasia in medulloblastomas- defining the nodular/desmoplastic variant and its biological behavior. Brain Pathol 17:151-164, 2007. (Pubitemid 46466135)
22. Moschovi M, Alexiou GA, Patereli A, Siozos G, Sfakianos G, Prodromou N, et al: Immunohistochemical expression of cell-cycle regulators in pediatric embryonal brain tumors. J Neurooncol 109:529-534, 2012.
23. Moschovi M, Alexiou GA, Patereli A, Stefanaki K, Doussis- Anagnostopoulou I, Stofas A, et al: Prognostic significance of cyclin A and B1 in pediatric embryonal tumors. J Neurooncol 103:699-704, 2011.
24. Moschovi M, Koultouki E, Stefanaki K, Sfakianos G, Tourkantoni N, Prodromou N, et al: Prognostic significance of angiogenesis in relation to Ki-67, p-53, p-27, and bcl-2 expression in embryonal tumors. Pediatr Neurosurg 47:241-247, 2011.
25. Murshid A, Gong J, Stevenson MA, Calderwood SK: Heat shock proteins and cancer vaccines: Developments in the past decade and chaperoning in the decade to come. Expert Rev Vaccines 10:1553-1568, 2011.
26. Northcott PA, Korshunov A, Witt H, Hielscher T, Eberhart CG, Mack S, et al: Medulloblastoma comprises four distinct molecular variants. J Clin Oncol 29:1408-1414, 2011.
27. Ohba S, Hirose Y, Yoshida K, Yazaki T, Kawase T: Inhibition of 90-kD heat shock protein potentiates the cytotoxicity of chemotherapeutic agents in human glioma cells. Laboratory investigation. J Neurosurg 112:33-42, 2010.
28. Panner A, Murray JC, Berger MS, Pieper RO: Heat shock protein 90alpha recruits FLIPS to the death-inducing signaling complex and contributes to TRAIL resistance in human glioma. Cancer Res 67:9482-9489, 2007. (Pubitemid 47535938)
29. Ray A, Ho M, Ma J, Parkes RK, Mainprize TG, Ueda S, et al: A clinicobiological model predicting survival in medulloblastoma. Clin Cancer Res 10:7613-7620, 2004. (Pubitemid 39557524)
30. Robinson G, Parker M, Kranenburg TA, Lu C, Chen X, Ding L, et al: Novel mutations target distinct subgroups of medulloblastoma. Nature 488:43-48, 2012.
31. Stefanaki K, Alexiou GA, Prodromou N: Embryonal brain tumours in children. Encephalos 49:1-8, 2012.
32. Taylor MD, Northcott PA, Korshunov A, Remke M, Cho YJ, Clifford SC, et al: Molecular subgroups of medulloblastoma: The current consensus. Acta Neuropathol 123:465-472, 2012.
33. Vargas-Roig LM, Fanelli MA, López LA, Gago FE, Tello O, Aznar JC, et al: Heat shock proteins and cell proliferation in human breast cancer biopsy samples. Cancer Detect Prev 21: 441-451, 1997. (Pubitemid 27413987)
34. von Hoff K, Hartmann W, von Bueren AO, Gerber NU, Grotzer MA, Pietsch T, et al: Large cell/anaplastic medulloblastoma: outcome according to myc status, histopathological, and clinical risk factors. Pediatr Blood Cancer 54:369-376, 2010.
35. Yiu CC, Chanplakorn N, Chan MS, Loo WT, Chow LW, Toi M, et al: Down-regulation of heat-shock protein 70 (HSP- 70) correlated with responsiveness to neoadjuvant aromatase inhibitor therapy in breast cancer patients. Anticancer Res 30:3465-3472, 2010.